Molecular Basis of Antithrombin Type I Deficiency: The First Large In-frame Deletion and Two Novel Mutations in Exon 6

Summary

We report three novel mutations accounting for cases of inherited type I antithrombin (AT) deficiency. Using the polymerase chain reaction (PCR) and direct sequencing of the coding sequences of the AT gene, we found one mutation in exon 4 and two in exon 6. A deletion of 105 bp causing an in-frame deletion of 35 amino acids between Tyr 240 and Gly 276 was found in exon 4. In a second kindred, deletion of two adenines in codon 412-413 introduced a frameshift and a stop codon at position 431. The last mutation was an insertion of ACCG in codon 387, generating a frameshift with a stop codon located at the normal position.

The finding of a sequence repeat of nine residues located at the 5’and 3’ ends of the deleted fragment might explain the 105 bp deletion by slippage and mispairing at the replication fork during DNA synthesis. The second mutation is the fourth described within a region of six amino acids (between Phe 408 and Arg 413), which seems to be a cluster of mutations. In this case, the presence of a double repeat sequence - TTCCT and AACA - flanking this region could be particularly favorable for slipped mispairing.

These results confirm that human gene mutations are not random events but are strongly influenced by DNA flanking sequences.

• References

• 1 Lane DA, Olds RJ, Thein SL. Antithrombin and its deficiency states. Blood Coag Fibrinolysis 1992; 3: 315
• 2 Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrhag 1965; 13: 516
• 3 Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Blajchman MA, Perry D, Emmerich J, Aiach M. Antithrombin III mutation database: first update. Thromb Haemost 1993; 70: 361
• 4 Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216
• 5 Bock SC, Wion KL, Vehar GA, Lawn RM. Cloning and expression of the cDNA for human antithrombin III. Nucl Acid Res 1982; 10: 8113
• 6 Aiach M, Nora M, Fiessinger JN, Roncato M, Francis D, Alhenc-Gelas M. A functional abnormal antithrombin III (AT III) deficiency: AT III Charle-ville. Thromb Res 1985; 39: 559
• 7 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487
• 8 Vidaud D, Emmerich J, Sirieix ME, Sié P, Alhenc-Gelas M, Aiach M. Molecular basis for anti thrombin III type I deficiency: Three novel mutations located in exon VI. Blood 1991; 78: 2305
• 9 Gandrille S, Vidaud D, Emmerich J, Clauser E, Sié P, Fiessinger JN, Alhenc-Gelas M, Priollett P, Aiach M. Molecular basis for antithrombin III quantitative deficiencies: A stop codon in exon IIIa and a frameshift in exon VI. Br J Haematol 1991; 78: 408
• 10 Del Sal G, Manfioletti G, Schneider C. The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagem-ids, phages or plasmids suitable for sequencing. Bio Techniques 1989; 7: 514
• 11 Lane DA, Ireland H, Olds RJ, Thein SL, Aiach M. Antithrombin III: a database of mutations. Thromb Haemost 1991; 66: 657
• 12 Fernandez-Rachubinski RA, Rachubinski RA, Blajchman MA. Partial deletion of antithrombin III allele in a kindred with a type I deficiency. Blood 1992; 80: 1476
• 13 Prochownik EV, Antonarakis S, Bauer KA, Rosenberg RD, Fearon ER, Orkin SH. Molecular heterogeneity of inherited antithrombin III deficiency. N Engl J Med 1983; 308: 1549
• 14 Efstratiadis A, Posakony JW, Maniatis T, Lawn R, O“Connell C, Spritz RA, DeRiel JL, Forget BG, Weissman SM, Slightom JL, Blechl AE, Smithies O, Baralle FE, Shoulders CC, Proudfoot NJ. The structure and evolution of the human β-globin gene family. Cell 1980; 21: 653
• 15 Cooper DM, Krawczak M. Gene deletions. In: Human gene mutation Cooper DN, Krawczak M. (eds). Bios Scientific Publishers; Oxford, UK: 1993: 163
• 16 Grundy CB, Thomas F, Milar DS, Krawczak M, Melissari E, Lindo V, Moffat E, Kakkar VV, Cooper DN. Recurrent deletion in the human antithrombin III gene. Blood 1991; 78: 1027
• 17 Olds RJ, Lane DA, Ireland H, Finazzi G, Barbui T, Abildgaard U, Girolami A, Thein SL. A common point mutation producing type la antithrombin III deficiency: AT 129 CGA to TGA (Arg to Stop ). Thrombos Res 1991; 64: 621
• 18 Vidaud D, Gandrille S, Emmerich J, Sirieix M, Alhenc-Gelas M, Fiessinger JN, Si’ P, Gouault M, Aiach M. Identification of 6 novel mutations responsible for type I AT III deficiencies. Thromb Haemost 1991; 65: 762
• 19 Chowdhury V, Olds RJ, Lane DA, Conard J, Pabinger I, Ryan K, Bauer KA, Bhavani M, Abildgaard U, Finazzi G, Castaman G, Mannucci PM, Thein SL. Identification of none novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Haematol 1993; 84: 656
• 20 Daly ME, Perry DJ, Harper PL, Carrell RW. The molecular basis of quantitative antithrombin deficiency in 8 unrelated families. Br J Haematol 1992; 80: 15
• 21 Olds RJ, Lane DA, Beresford CH, Abildgaard U, Hughes PM, Thein SL. A recurrent deletion in the anti thrombin gene, AT 106-108 (-6bp) identified by DNA heteroduplex detection. Genomics 1993; 16: 298
• 22 Brodbeck RM, Brown JL. Secretion of α-1-proteinase inhibitor requires an almost full length molecule. J Biol Chem 1992; 267: 294